Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy

AIDS

Volumn 12, Issue 12, 1998, Pages 1459-1464

  Heard, Isabelle ^a,c   Schmitz, Valérie ^b   Costagliola, Dominique ^a   Orth, Gérard ^b   Kazatchkine, Michel D ^a  

^a INSERM   (France)

^b INSTITUT PASTEUR   (France)

^c HÔPITAL BROUSSAIS   (France)

Author keywords

Antiretroviral therapy; Cervical dysplasia; HIV; Human papillomavirus

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; DIDANOSINE; INDINAVIR; LAMIVUDINE; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR; STAVUDINE; VIRUS DNA; ZIDOVUDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; COLPOSCOPY; CYTOLOGY; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LYMPHOCYTE COUNT; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOUTHERN BLOTTING; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DISEASE; VIRUS LOAD; WART VIRUS;

ADULT; ANTI-HIV AGENTS; BLOTTING, SOUTHERN; CARCINOMA, SQUAMOUS CELL; CD4 LYMPHOCYTE COUNT; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; FEMALE; HIV; HIV SEROPOSITIVITY; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; RNA, VIRAL; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; VIRAL LOAD;

EID: 0032552125     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199812000-00007     Document Type: Article

References (28)

1. Schäfer A, Friedmann W, Mielke M, Schwartländer B, Koch MA: The increased frequency of cervical dysplasia-neoplasia in women infected with the human immunodeficiency virus is related to the degree of immunosuppression. Am J Obstet Gynecol 1991, 164:593-599.
2. Vermund SH, Kelley KF, Klein RS, et al.: High risk of human papillomavirus infection and cervical squamous intraepithelial lesions among women with symptomatic human immunodeficiency virus infection. Am J Obstet Gynecol 1991, 165:392-400.
3. Wright TC, Ellerbrock TV, Chiasson M-A, et al.: Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of Papanicolaou smears. Obstet Gynecol 1994, 84:591-597.
4. Sun XW, Ellerbrock TV, Lungu O, Chiasson M-A, Bush TJ, Wright TC: Human papillomavirus infection in human immunodeficiency virus-seropositive women. Obstet Gynecol 1995, 85:680-686.
5. Maiman M, Fruchter RC, Serur E, Remy J, Feuer C, Boyce J: Human immunodeficiency virus infection and cervical neoplasia. Gynecol Oncol 1990, 38:377-382.
6. Fruchter RG, Maiman M, Sedlis A, Bartley L, Camilien L, Arrastia CD: Multiple recurrences of cervical intraepithelial neoplasia in women with the human immunodeficiency virus. Obstet Gynecol 1996, 87:338-344.
7. Adachi A, Fleming I, Burk RD, Ho GYF, Klein RS: Women with human immunodeficiency virus infection and abnormal Papanicolaou smears: a prospective study of colposcopy and clinical outcome. Obstet Gynecol 1993, 81:372-377.
8. Heard I, Bergeron C, Jeannel D, Henrion R, Kazatchkine MD: Papanicolaou smears in human immunodeficiency virus-seropositive women during follow-up. Obstet Gynecol 1995, 86:749-753.
9. Petry KU, Scheffel D, Bode U, et al.: Cellular immunodeficiency enhances the progression of human papillomavirus-associated cervical lesions. Int J Cancer 1994, 57:836-840.
10. Klein RS, Ho GYF, Vermund SH, Fleming I, Burk RD: Risk factors for squamous intraepithelial lesions on pap smear in women at risk for immunodeficiency virus infection. J Infect Dis 1994, 170:1404-1409.
11. Heard I, Jeannel D, Bergeron C, Saada M, Henrion R, Kazatchkine MD: Lack of behavioral risk factors for squamous intraepithelial lesions (SIL) in HIV-infected women. Int J STD AIDS 1997, 8:388-392.
12. Ho GYF, Burk RD, Fleming I, Klein RS: Risk of genital human papillomavirus infection in women with human immunodeficiency virus-induced immunosuppression. Int J Cancer 1994, 56:788-792.
13. Vernon SD, Icenogle JP, Johnson PR, Reeves WC: Human papillomavirus, human immunodeficiency virus, and cervical cancer: newly recognized associations? Infect Agents Dis 1993, 1:319-324.
14. Hammer SM, Squires KE, Hughes MD, et al.: A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Med 1997, 337:725-733.
15. Stafl A, Wilbanks GD: An international terminology of colposcopy: report of the Nomenclature Committee of the International Federation of Cervical Pathology and Colposcopy. Obstet Gynecol 1991, 77:313-314.
16. Kurman RJ, Henson DE, Herbst AL, Noller KL, Schiffman MH: Interim guidelines for management of abnormal cervical cytology. JAMA 1995, 271:1866-1869.
17. Ting Y, Manos MM: Detection and typing of genital human papillomaviruses. In PCR Protocols: a Guide to Methods and Applications. Edited by Innis MA, Gelfand DH, Sninsky JJ, White TJ. San Diego: Academic Press; 1990;356-367.
18. Aynaud O, Tranbaloc P, Orth G: Lack of evidence for a role of human papillomaviruses in transitional cell carcinoma of the bladder. J Urol 1998, 159:86-89.
19. de Roda Husman A-M, Walboomers JMM, van den Brule AJC, Meijer CJLM, Snijders PJF: The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995, 76:1057-1062.
20. Marte C, Kelly P, Cohen M, et al.: Papanicolaou smear abnormalities in ambulatory care sites for women infected with the human immunodeficiency virus. Am J Obstet Gynecol 1992, 166:1232-1217.
21. Sun XW, Kuhn L, Ellerbrock TV, Chidsson M-A, Bush TJ, Wright TC: Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med 1997, 337:1343-1349.
22. Maiman M, Fruchter RG, Serur E, Levine PA, Arrastia CD, Sedlis A: Recurrent cervical intraepithelial neoplasia in human immunodeficiency virus-seropositive women. Obstet Gynecol 1993, 82:170-174.
23. Cuzick J, Terry G, Ho L, Hollingworth T, Anderson M: Human papillomavirus type 16 DNA in cervical smears as predictor of high-grade cervical intraepithelial neoplasia. Lancet 1992, 339:959-960.
24. Ho GYF, Burk RD, Klein S, et al.: Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995, 87:1365-1371.
25. Remmink AJ, Walhoomers JMM, Helmerhorst TJM, et al.: The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer 1995, 61:306-311.
26. Clemetson DB, Moss GB, Willeford DM, et al.: Detection of HIV DNA in cervical and vaginal secretions. Prevalence and correlates among women in Nairobi, Kenya. JAMA 1993, 269:2860-2864.
27. Wit FWNM, Sol CJA, Renwick N, et al.: Regression of AIDS-related Kaposi's sarcoma associated with clearance of human herpesvirus-8 from peripheral blood mononuclear cells following initiation of antiretroviral therapy. AIDS 1998, 12:218-219.
28. Neyts J, De Clercq E: Antiviral drug susceptibility of human herpesvirus 8. Antimicrob Agents Chemother 1997, 41:2754-2756.